Bionik Labs raises $1.95 mln to sell robotics products in China
Canadian medical device and robotics company Bionik Laboratories Corp has secured $1.95 million in funding from Ginger Capital Investment Holding, a Hong Kong investment and management consulting firm. Ginger Capital will invest $500,000 directly into the company and $1.45 million into a joint venture established with Bionik. The joint venture will include an exclusive license to sell Bionik's products in China. Founded in 2009, Toronto-based Bionik develops robotics technologies that provide rehabilitation solutions to individuals with neurological and mobility challenges.
24 May 2017•5 mins read
